UK livestock supplement specialist Fevara has signed an exclusive five-year distribution agreement with Brazil-based Oceana Minerals to market LithoNutri across Great Britain and Ireland, expanding its integrated nutrition portfolio as it pursues larger dairy and beef customers with sustainable alternatives to traditional ruminal buffering agents. The agreement enables Fevara to leverage existing distribution channels while providing technical development support, accelerating its strategy to bundle complementary products and increase wallet share per customer relationship amid regulatory pressure on synthetic additives.

What’s Inside:

  1. Pilgrim's Pride Completes Debt Buyback at 53% Proration After Over-Subscription

  2. Charterhouse Takes Animalcare Private in £235M Deal as Animal Health Consolidation Accelerates

  3. Virginia Poultry Cooperative Invests $114M in East Coast's Largest Feed Mill

  4. Kemin Launches Connected Water Disinfection System as Farm Automation Expands

  5. UK Research Institute Partners with US Biotech on RNA Livestock Vaccines

Pilgrim's Pride Completes Debt Buyback at 53% Proration After Over-Subscription

The poultry processor received $471.5 million in tenders for its $250 million maximum tender offer targeting 6.25% senior notes due 2033, forcing proration at approximately 53% as institutional demand exceeded capacity by nearly 90%. The over-subscription reflects investor confidence in poultry sector fundamentals while constraining Pilgrim's ability to optimize its debt stack ahead of potential refinancing needs in 2027-2028, despite achieving reduced debt service costs through the premium buyback.

Charterhouse Takes Animalcare Private in £235M Deal as Animal Health Consolidation Accelerates

Private equity firm Charterhouse Capital Partners agreed to acquire York-based Animalcare Group for £235.2 million at a 36% premium, removing a 165-brand animal health platform from public markets to enable accelerated R&D investment and acquisition-led expansion against industry consolidators like Zoetis and Elanco. The investment aligns with Animalcare's 2030 targets of £150 million revenue and 25% EBITDA margins, reflecting PE confidence in the company's buy-and-build capabilities following its successful £62.2 million Randlab acquisition strategy.

Virginia Poultry Cooperative Invests $114M in East Coast's Largest Feed Mill

Virginia Poultry Growers Cooperative will build a 2-million-cubic-foot feed mill in Rockingham County as part of a $113.9 million expansion, establishing the East Coast's largest grain storage capacity to process an additional 4.5 million turkeys annually while sourcing 2.4 million more bushels of Virginia grain. The investment strengthens the grower-owned cooperative's feed cost position and expands producer opportunities in the Shenandoah Valley, positioning it to compete more effectively against integrated processors like Butterball and Cargill in the premium turkey segment.

Kemin Launches Connected Water Disinfection System as Farm Automation Expands

Iowa-based ingredient manufacturer Kemin Industries introduced EDIE Generation 2, an automated chlorine dioxide application system combining real-time monitoring, mobile connectivity, and intelligent water quality management to reduce manual intervention while providing producers with data-driven biosecurity capabilities. The launch reflects accelerating adoption of connected farm technologies, positioning Kemin to capture recurring revenue from both equipment sales and chemical consumables as producers prioritize automated systems to address labor constraints and regulatory compliance requirements.

UK Research Institute Partners with US Biotech on RNA Livestock Vaccines

The Centre for Veterinary Vaccine Innovation and Manufacturing at Pirbright Institute has partnered with Tiba Biotech to advance RNA-based vaccine candidates for livestock diseases including foot-and-mouth disease, leveraging Tiba's RNABL delivery platform as US funding for RNA vaccine research contracts. Backed by Gates Foundation funding, the collaboration reflects strategic extension of pandemic-validated RNA technology into animal health, potentially accelerating response capabilities for emerging livestock diseases while positioning UK institutions to lead veterinary RNA vaccine development.

More From Protein Signals